Literature DB >> 15064481

Prognostic and predictive factors.

Michael Scott1, Peter A Hall.   

Abstract

Mesh：

Substances：

Year:  2004        PMID： 15064481     DOI： 10.1385/1-59259-760-2:001

Source DB:  PubMed          Journal:  Methods Mol Med        ISSN： 1543-1894


× No keyword cloud information.
  3 in total

1.  KRAS and MAPK1 gene amplification in type II ovarian carcinomas.

Authors:  Mohammed Tanjimur Rahman; Kentaro Nakayama; Munmun Rahman; Hiroshi Katagiri; Atsuko Katagiri; Tomoka Ishibashi; Masako Ishikawa; Emi Sato; Kouji Iida; Naomi Nakayama; Noriyuki Ishikawa; Kohji Miyazaki
Journal:  Int J Mol Sci       Date:  2013-07-02       Impact factor: 5.923

2.  Nucleus accumbens-1/GADD45GIP1 axis mediates cisplatin resistance through cellular senescence in ovarian cancer.

Authors:  Kentaro Nakayama; Munmun Rahman; Mohammed Tanjimur Rahman; Kohei Nakamura; Emi Sato; Hiroshi Katagiri; Tomoka Ishibashi; Masako Ishikawa; Kouji Iida; Sultana Razia; Noriyuki Ishikawa; Satoru Kyo
Journal:  Oncol Lett       Date:  2017-04-26       Impact factor: 2.967

3.  CCNE1 amplification is associated with aggressive potential in endometrioid endometrial carcinomas.

Authors:  Kentaro Nakayama; Mohammed Tanjimur Rahman; Munmun Rahman; Kohei Nakamura; Masako Ishikawa; Hiroshi Katagiri; Emi Sato; Tomoka Ishibashi; Kouji Iida; Noriyuki Ishikawa; Satoru Kyo
Journal:  Int J Oncol       Date:  2015-11-26       Impact factor: 5.650
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.